+91 80 6852 7777, +91 80 2839 7974, 75, 78 Careers

Click ingredient brand name for product website.

Code Product Name Standardization Functional Activity
0301 Calebin A (1) New
98% Calebin A Supports joint function
Supports liver health
Supports metabolic health
Supports healthy body composition
0336 Chrysin 97% Dihydroxyflavone Supports normal inflammation response
Supports cognitive function
Sports nutrition
0522 Diindolylmethane (DIM) 98% DIM High ORAC
Bone health
0472 Forskolin Carbonate 98% Forskolin Carbonate Supports healthy body composition
0912 Indole-3-Carbinol 99.6% Indole-3-Carbinol High ORAC
Supports joint function
2100 Ipriflavone 98.5% Ipriflavone Bone health
1458 Oxyresveratrol (2)
95% Oxyresveratrol High ORAC
Supports immune system
Support heart health
1819 Resveratrol (2)
99% Resveratrol High ORAC
Supports immune system
Support heart health
2022 Tetrahydrocurcuminoids ODS
Curcumin C3 Reduct® ODS
95% Tetrahydrocurcuminoids Supports normal inflammation response
Oral health


(1) Calebin A (CurCousin™ )

 US 8,933,121; US 9,328,330; AU2012366253; AU2014203122; CA2857543; JP6374716; KR10-1702702; NZ614076; NZ 715053; RU2543334; SG192695; ZA2013/05918; ZL201280012577.3: Anti-obesity potential of calebin A

 US 9,610,273; US 9,668,999; AU2014202312; CA2850999; CA2963383; EA027148; EP2937084; HK1210590; I-622384; JP6263707; KR10-1647549; NZ624269; MY-170067-A; PH1-2014-000244: Method for the treatment of hypercholesterolemia

 IDP000064827: Calebin A and its effect on hypercholesterolemia

 US 9,220,703; AU2014201769; CA2935898;EP2893926; JP6142446; KR10-1685263; KR10-1685333; MY-175867-A; NZ622909; PH1-2016-501138; SG11201605336Y: Composition and method for the protection of articular cartilage

 EA027614: Use of calebin A to protect mammalian articular cartilage from pathological damage

 US 9,365,486; AU2014203764; CA2858126; EA027726; EP2963007; HK1217689; JP6490927; KR10-1629561; NZ627247: Synthesis of calebin A and its biologically active analogs

 HK1210028: Calebin A for articular cartilage

 EP3085370: Calebin A for inducing lipolysis

 US 9,737,502; CA2893321; IDP000067993; JP6336943; KR10-1763474; MY-182000-A; PH1-2015-000188; RU2643297; SG10201503805X: Calebin A for hepatic steatosis

 US 9,539,232; CA2941050; RU2653103: Calebin A for osteoporosis

 EP2663185; HK1190874: Calebin A for use in the treatment of inflammation and obesity

(2) Oxyresvenox® / Resvenox®

 US 7,253,324: Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers



These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.